These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Looking ahead: where to next for animal models of bronchopulmonary dysplasia? Nardiello C; Mižíková I; Morty RE Cell Tissue Res; 2017 Mar; 367(3):457-468. PubMed ID: 27917436 [TBL] [Abstract][Full Text] [Related]
43. Disease-specific dynamic biomarkers selected by integrating inflammatory mediators with clinical informatics in ARDS patients with severe pneumonia. Chen C; Shi L; Li Y; Wang X; Yang S Cell Biol Toxicol; 2016 Jun; 32(3):169-84. PubMed ID: 27095254 [TBL] [Abstract][Full Text] [Related]
44. Systemic Administration of Human Bone Marrow-Derived Mesenchymal Stromal Cell Extracellular Vesicles Ameliorates Aspergillus Hyphal Extract-Induced Allergic Airway Inflammation in Immunocompetent Mice. Cruz FF; Borg ZD; Goodwin M; Sokocevic D; Wagner DE; Coffey A; Antunes M; Robinson KL; Mitsialis SA; Kourembanas S; Thane K; Hoffman AM; McKenna DH; Rocco PR; Weiss DJ Stem Cells Transl Med; 2015 Nov; 4(11):1302-16. PubMed ID: 26378259 [TBL] [Abstract][Full Text] [Related]
45. Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia. Yeh TF; Chen CM; Wu SY; Husan Z; Li TC; Hsieh WS; Tsai CH; Lin HC Am J Respir Crit Care Med; 2016 Jan; 193(1):86-95. PubMed ID: 26351971 [TBL] [Abstract][Full Text] [Related]
46. Trends in Care Practices, Morbidity, and Mortality of Extremely Preterm Neonates, 1993-2012. Stoll BJ; Hansen NI; Bell EF; Walsh MC; Carlo WA; Shankaran S; Laptook AR; Sánchez PJ; Van Meurs KP; Wyckoff M; Das A; Hale EC; Ball MB; Newman NS; Schibler K; Poindexter BB; Kennedy KA; Cotten CM; Watterberg KL; D'Angio CT; DeMauro SB; Truog WE; Devaskar U; Higgins RD; JAMA; 2015 Sep; 314(10):1039-51. PubMed ID: 26348753 [TBL] [Abstract][Full Text] [Related]
47. Beneficial Effect of Etanercept on Hyperoxic Lung Injury Model in Neonatal Rats. Oncel MY; Yurttutan S; Alyamac Dizdar E; Gokce IK; Gonul II; Topal T; Canpolat FE; Dilmen U J Invest Surg; 2016; 29(1):1-5. PubMed ID: 26305557 [TBL] [Abstract][Full Text] [Related]
48. Targeting heme oxygenase-1 and carbon monoxide for therapeutic modulation of inflammation. Ryter SW; Choi AM Transl Res; 2016 Jan; 167(1):7-34. PubMed ID: 26166253 [TBL] [Abstract][Full Text] [Related]
54. Intratracheal transplantation of human umbilical cord blood-derived mesenchymal stem cells dose-dependently attenuates hyperoxia-induced lung injury in neonatal rats. Chang YS; Choi SJ; Sung DK; Kim SY; Oh W; Yang YS; Park WS Cell Transplant; 2011; 20(11-12):1843-54. PubMed ID: 23167961 [TBL] [Abstract][Full Text] [Related]
55. Vasculoprotective effects of heme oxygenase-1 in a murine model of hyperoxia-induced bronchopulmonary dysplasia. Fernandez-Gonzalez A; Alex Mitsialis S; Liu X; Kourembanas S Am J Physiol Lung Cell Mol Physiol; 2012 Apr; 302(8):L775-84. PubMed ID: 22287607 [TBL] [Abstract][Full Text] [Related]
56. Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? Bernardo ME; Pagliara D; Locatelli F Bone Marrow Transplant; 2012 Feb; 47(2):164-71. PubMed ID: 21478914 [TBL] [Abstract][Full Text] [Related]
57. Caveolin-1 mediates Fas-BID signaling in hyperoxia-induced apoptosis. Zhang M; Lee SJ; An C; Xu JF; Joshi B; Nabi IR; Choi AM; Jin Y Free Radic Biol Med; 2011 May; 50(10):1252-62. PubMed ID: 21382479 [TBL] [Abstract][Full Text] [Related]
58. The biological activity of FasL in human and mouse lungs is determined by the structure of its stalk region. Herrero R; Kajikawa O; Matute-Bello G; Wang Y; Hagimoto N; Mongovin S; Wong V; Park DR; Brot N; Heinecke JW; Rosen H; Goodman RB; Fu X; Martin TR J Clin Invest; 2011 Mar; 121(3):1174-90. PubMed ID: 21285513 [TBL] [Abstract][Full Text] [Related]
59. Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery. Porada CD; Almeida-Porada G Adv Drug Deliv Rev; 2010 Sep; 62(12):1156-66. PubMed ID: 20828588 [TBL] [Abstract][Full Text] [Related]